Synagistics Limited — Capital/Financing Update 2018

Sep 17, 2018

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [66 x 45] intentionally omitted <==

==> picture [34 x 40] intentionally omitted <==

OP FINANCIAL LIMITED 東英金融有限公司[*]

(incorporated in the Cayman Islands with limited liability)

(Stock code: 1140)

VOLUNTARY ANNOUNCEMENT FORMATION OF JV COMPANY AND ENTERING INTO RELEVANT COOPERATION AGREEMENTS

This announcement is made by OP Financial Limited (the “ Company ”) and its subsidiaries (collectively, the “ Group ”) on a voluntary basis to provide the latest business development of the Group to the shareholders and potential investors of the Company.

The Company is pleased to announce that, as of the date of this announcement, the Company entered into a series of cooperation agreements with a wholly-owned subsidiary of DaChan Food (Asia) Limited (“ DaChan Food ”, stock code: 3999.HK) through OP iCarbonX Investment Limited (東英碳雲投資有限公司), a JV company established by the Company and iCarbonX Group Limited (“ iCarbonX ”), pursuant to which the parties shall make joint contribution to establish a JV company, namely Better Me Precision Nutrition Limited (“ Better Me ”). Better Me will integrate the superior resources of the Company, DaChan Food and iCarbonX in their respective areas, actively tap into the cross-border collaboration capacity of financial capital, combine the experience and advantages in R&D and production of healthy food as well as food & beverage operation and management, and conduct dynamic and intelligent analysis of the life data of membership using biotechnology, big data of life and AI technology. In addition, Better Me seeks to provide customized and precise nutrition food & beverage solutions in response to the National Nutrition Plan Policy of the PRC and to cater to the demand for upgrading consumption, especially for precision nutrition and health, from modern consumers.

As mentioned by the Company in its 2017/2018 Annual Report, the Company takes “Crossborder Integration and Collaboration” as its development mission and actively captures investment opportunities in the great healthcare industry. The cooperation with DaChan Food and iCarbonX is one step in the Company’s development in the great healthcare industry. The Board believes that such strategic cooperation will combine the Company’s investment and financing advantages and enterprises’ industrial technology advantages to realize resource integration and value growth and bring long-term return for our shareholders.

– 1 –

ABOUT BETTER ME PRODUCTS

The Better Me series of products comprises DaChan Food’s existing products which have been operating for more than two years and accumulated a large number of consumers, laying the foundation for the promotion and membership conversion of precision nutrition products in the future. Better Me mainly targets white-collars and fitness enthusiasts who stress on nutrition, health and body shaping. The customers with membership may purchase the personalized nutrition diet solutions and related products by using Better Me precision nutrition APP or mini app, with products delivered through channels including meal delivery service, cold chain transportation, gymnasia under offline cooperation and new retail supermarkets.

ABOUT DACHAN FOOD

DaChan Food (Asia) Limited is a fully integrated animal protein product provider that adopts safe protein food supply chain, strict and standard quality control and traceability systems. Its products range from feeds, poultry and advanced nutritional formulas for aquatic animals to processed foods. DaChan Food has built competitive brand awareness in market and has longterm reliable relationships with famous domestic and international clients. It is a designated chicken supplier of KFC in China, one of the designated suppliers of the exclusive purchase agent of McDonald’s China, and a premium Chinese chicken product exporter designated by Ito Yokado in Japan and the 7-Eleven convenience store chain.

ABOUT ICARBONX

iCarbonX was established in October 2015 and its main founding team includes the world’s top biotechnology experts with extensive experience in omics technology, medical service, bio-data analysis, artificial intelligence and data mining. iCarbonX aims to create an ecosystem for digital life, focused on the big data of life of consumers, the Internet and artificial intelligence. Currently, iCarbonX has gained its leadership in global digital life and precision health management. In April 2016, iCarbonX completed the A round of financing led by Tencent, with a valuation of US$1 billion. Based on the world’s leading, exponentially growing digital life network, iCarbonX is committed to providing consumers with customized health solutions to help everyone better manage health.

ABOUT THE COMPANY

OP Financial Limited (1140.HK) is a cross-border and cross-sector investment company listed on the Main Board of Hong Kong Clearing and Exchanges Limited, with a portfolio covering listed and non-listed companies across multiple regions and sectors around the globe. The Company has adopted different methods such as long-term core shareholding, mid-term PE/ VC, and short-term arbitrage to build various investment portfolios in a flexible way to create returns for shareholders.

– 2 –

Shareholders and potential investors of the Company should thus exercise caution when dealing in the shares of the Company.

By order of the Board OP Financial Limited Zhang Gaobo Executive Director, Chairman & CEO

Hong Kong, 17 September 2018

As at the date of this announcement, the Board comprises three executive Directors, namely, Mr. Zhang Zhi Ping, Mr. Zhang Gaobo and Mr. Zhang Weidong; three non-executive Directors, namely, Dr. Wu Zhong, Mr. Chen Yuming and Dr. Fu Weigang; and three independent non-executive Directors, namely, Mr. Kwong Che Keung, Gordon, Professor He Jia and Mr. Wang Xiaojun.

• For identification purposes only

– 3 –